Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Broadhead

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Endocrinology|August 1, 1983
The effects of daily administration of single and multiple injections of gonadotropin-releasing hormone on pituitary and gonadal function in the hypogonadal (hpg) mouseH M Charlton, D M Halpin, C Iddon, et al.
Scientific Reports|April 26, 2016
PSD95 nanoclusters are postsynaptic building blocks in hippocampus circuitsMatthew J Broadhead, Mathew H Horrocks, Fei Zhu, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 1998
Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01H M Prinssen, C F Molthoff, R H Verheijen, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Endocrinology|August 1, 1983
The effects of daily administration of single and multiple injections of gonadotropin-releasing hormone on pituitary and gonadal function in the hypogonadal (hpg) mouseH M Charlton, D M Halpin, C Iddon, et al.
Scientific Reports|April 26, 2016
PSD95 nanoclusters are postsynaptic building blocks in hippocampus circuitsMatthew J Broadhead, Mathew H Horrocks, Fei Zhu, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 1998
Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01H M Prinssen, C F Molthoff, R H Verheijen, et al.
Pageof 4